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Satisfaction with Intrauterine Device Insertion Procedure Among
Adolescent and Young Adult Women in a Clinical Trial
Abstract
OBJECTIVE:
To evaluate satisfaction with intrauterine device (IUD) insertion procedures among adolescent and young
adult women.
METHODS:
This secondary analysis of data from a multisite, single-blind, sham-controlled randomized trial of women
having a levonorgestrel 13.5-mg IUD inserted enrolled participants from March 2015 through July 2016 at
three family planning clinics in Philadelphia, Pennsylvania. Eligible participants were 14-22 years of age,
nulliparous, not pregnant, and English-speaking. Randomization was computer-generated allocation in block
sizes of four to a 1% lidocaine paracervical or sham block. Only patients were blinded. Satisfaction was
measured with three items that assessed overall satisfaction with the procedure, whether participants would
recommend the IUD to a friend, and the perception that the IUD was worth the discomfort. Predictors
included demographics, sexual and reproductive history, pain after IUD insertion, and treatment group.
RESULTS:
Ninety-five women enrolled; 93 (97.9%) were included in the analysis. Forty-five (47.4%) were white, 34
(36.0%) were black, 62 (66.0%) were privately insured, and 75 (79.0%) had used contraception previously.
Most (n=73 [76.8%]) reported high overall satisfaction with the procedure, 64 (67.4%) would recommend an
IUD to a friend, and 79 (83.2%) perceived the IUD was worth the discomfort. The odds of reporting high
overall satisfaction were lower among adolescents compared with young adults (odds ratio [OR] 0.07, 95% CI
0.008-0.68); those who never had a gynecologic examination compared with those who had (OR 0.26, 95%
CI 0.07-0.99); and decreased as pain score increased (OR 0.96, 95% CI 0.94-0.99). Higher pain scores were
negatively correlated with the odds of recommending an IUD to a friend and perceiving the IUD was worth
the discomfort.
CONCLUSION:
Adolescent and young adult women report high levels of satisfaction after the IUD insertion procedure. Young
age, lack of experience with gynecologic examinations, and high pain were inversely related to satisfaction.
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Abstract
OBJECTIVE—To evaluate satisfaction with intrauterine device (IUD) insertion procedures 
among adolescent and young adult women.
METHODS—This secondary analysis of data from a multisite, single-blind, sham-controlled 
randomized trial of women having a levonorgestrel 13.5 mg IUD inserted enrolled participants 
from March 2015 through July 2016 at 3 family planning clinics in Philadelphia, Pennsylvania. 
Eligible women were 14 to 22 years, nulliparous, not pregnant, and English speaking. 
Randomization was via computer generated allocation in block sizes of 4 to a 1% lidocaine 
paracervical or sham block. Only patients were blinded. Satisfaction was measured with 3-items 
that assessed overall satisfaction with the procedure, whether participants would recommend the 
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IUD to friend, and the perception that the IUD was worth the discomfort. Predictors included 
demographics, sexual and reproductive history, pain following IUD insertion, and treatment group.
RESULTS—Ninety-five women enrolled; 93 (97.9%) were included in the analysis. Forty-five 
(47.4%) were white, 34 (36.0%) were black, 62 (66.0%) privately insured, and 75 (79.0%) 
previously used contraception. Most (n=71, 76.8%) reported high overall satisfaction with the 
procedure, 62 (67.4%) would recommend an IUD to a friend, and 77 (83.2%) perceived the IUD 
was worth the discomfort. The odds of reporting high overall satisfaction were lower among 
adolescents compared to young adults (OR 0.07, 95% CI: 0.008, 0.68); those who never had a 
gynecologic exam compared to those who had (OR 0.26; 95% CI: 0.069, 0.99); and decreased as 
pain score increased (OR 0.96; 95% CI: 0.94, 0.99). Higher pain scores were negatively correlated 
with the odds of recommending an IUD to a friend and perceiving the IUD was worth the 
discomfort.
CONCLUSION—Adolescent and young adult women report high levels of satisfaction following 
the IUD insertion procedure. Young age, lack of experience with gynecologic exams, and high 
pain were inversely related to satisfaction.
Clinical Trial Registration—ClinicalTrials.gov, https://clinicaltrials.gov, NCT02352714.
INTRODUCTION
Although intrauterine devices (IUDs) have been available in the U.S. for decades, utilization 
rates remain low among adolescent and young adult women. Only 4% use IUDs compared 
to 12% of women over age 20 years.2–4 The contraceptives most commonly used by young 
women (pills, patch, and ring) are twenty times less effective than IUDs.5,6 Given the high 
rate of unintended pregnancies in this population, improving IUD use is important.5,6 
Barriers to IUD utilization including lack of knowledge, negative personal attitudes, negative 
social norms, and limited IUD access, particularly in pediatric care settings.7–9 Interventions 
have focused on improving access, promoting patient-centered counseling, and promoting 
long-acting methods.10,11
An understudied aspect of IUD utilization is women’s perceptions of the IUD insertion 
procedure. For young women, concern about discomfort during the insertion procedure is a 
major barrier to IUD use. Improving our understanding of young women’s experiences 
during the procedure may aid with counseling and service delivery, help address pre-
procedure anxiety, identify modifiable aspects of the procedure, and improve IUD uptake.
7–9,12
 Studies assessing young women’s satisfaction with the IUD measure satisfaction six to 
12 months after device placement; we are not aware of any studies assessing young women’s 
satisfaction immediately following IUD insertion.13–15 In the current study, we examine 
satisfaction with the IUD insertion procedure and predictors of satisfaction among 
adolescent and young adult women participating in a randomized clinical trial that examined 
the effectiveness of a 1% lidocaine paracervical nerve block on pain reported during IUD 
insertion compared to a sham block.
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MATERIALS AND METHODS
Study Design
This was a secondary analysis of data from a multisite, single-blind, sham-controlled 
randomized trial conducted at three clinics in Philadelphia, Pennsylvania from March 2015 
to July 2016 that involved one study visit. The CONSORT guidelines were followed to 
design and report the trial; full details regarding the trial are repored elsewhere.16 The 
protocol is available by request. Institutional Review Board (IRB) approval was obtained 
from the Children’s Hospital of Philadelphia (CHOP, which was the IRB of record), 
Hospital of the University of Pennsylvania, and Thomas Jefferson University, all of which 
performed study visits. Approval was also obtained from AccessMatters, which funds Title 
X clinics in southeastern Pennsylvania, which allowed study recruitment flyers to be posted 
in Title X clinics that refer adolescents to CHOP for IUD insertions. The trial was registered 
with Clinical trials.gov (NCT# NCT02352714).
Recruitment, Eligibility and Consent
Women presenting to a study site requesting a hormonal IUD were asked by a clinician if 
they were interested in talking with research staff about the study. Interested women seeking 
reproductive health services at a non-enrolling study site who saw a recruitment flyer called 
the study coordinator who described the study and scheduled a study visit. Patients were 
eligible for inclusion if they were between ages 14 to 22 years, nulliparous, not pregnant 
currently, not pregnant in the prior 6 weeks, interested in the Skyla IUD (levonorgestrel 
13.5mg IUD), and English speaking. The cut-off of 22 years, rather than 24 years, was 
chosen to minimize the number of older, young adult women. Patients were excluded if they 
did not meet medical eligibility criteria for an IUD;17 had a contraindication to taking 
amino-amide anesthetics or non-steroidal anti-inflammatory agents; were unwilling to be 
randomized; were at high risk for pregnancy; used narcotics or benzodiazepine in the prior 
24 hours; previously used an IUD; or had a prior unsuccessful IUD insertion. Women could 
enroll at a later date if inclusion criteria were not initially met. Written informed consent 
was obtained from all participants, regardless of age, since females 13 and older in 
Pennsylvania can legally consent for reproductive services and research studies regarding 
reproductive services, and because requiring parental permission for study participation 
would have compromised confidentiality.
Trial Procedures and Treatment Group Description
Participants completed a questionnaire assessing demographic characteristics and their 
medical and reproductive history. Prior to randomization, participants received 800 mg of 
ibuprofen orally at least 20 minutes prior to the procedure to reduce post-procedure pain.18 
Randomization was performed by a research coordinator in the Research Data Capture 
(REDCap) software in block sizes of 4 with stratification by age (14 – 17 or 18 – 22 years), 
race, and recruitment site after completion of the demographic questionnaire. Only patients 
were blinded to group assignment. The lidocaine block group received 1 mL of 1% lidocaine 
at the tenaculum site and 4.5 mL at 4 o’clock and 8 o’clock at the cervicovaginal junction. 
For the sham block, pressure was applied to these same three sites with the unbroken, wood 
end of a cotton-tipped applicator to depress the vaginal epithelium 1 mm. There was a 3-
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minute delay after administering the lidocaine and sham block before IUD insertion to allow 
onset of action for the lidocaine. IUD insertion followed the manufacturer’s instructions, 
including sounding the uterus before inserting the IUD. All devices were inserted by an 
experienced provider who was an attending physician or a family planning fellow.
After IUD insertion, clinicians completed a questionnaire assessing procedural details 
(uterine size and depth, need for dilation or ultrasound guidance, and adverse events). One 
item assessed provider-rated patient anxiety by asking if the patient’s general affect seemed 
“pleasant and appropriately engaging” or “anxious”. Following IUD insertion, a post-
procedure questionnaire was administered to participants by a research coordinator to rate 
their satisfaction with and discomfort during the procedure.
Participants who completed all study activities received $50 for their time. Devices were 
provided free of charge by the study funder. Participants’ insurance was billed for the 
clinical procedure fee. Clinicians were not compensated for performing the IUD insertion 
nor for completing the questionnaire.
Outcomes
Satisfaction with the IUD insertion procedure was measured using three single-item 
satisfaction measures adapted from items commonly used to assess satisfaction with various 
dimensions of clinical care. Overall satisfaction was assessed with an item that asked, “How 
would you rate your overall satisfaction with your IUD placement?” Response options 
ranged from “very dissatisfied” (1) to “very satisfied” (5). Participants were classified as 
satisfied if they responded “Very satisfied”. The second item asked if participants would 
“recommend an IUD to a friend”. Response options included, “Definitely yes”, “Probably 
yes”, “Neutral”, “Probably not”, “Definitely not”, and “Don’t know, No opinion”. 
Participants were classified as satisfied if they responded “Definitely yes”. The third item 
asked if getting the IUD “was worth the discomfort”. Response options were “Yes”, “No” or 
“Unsure”. Higher scores denoted greater satisfaction, higher IUD recommendation, or the 
belief that the procedure was worthwhile, respectively.
Covariates
Demographic variables included age, race, Hispanic ethnicity, marital status, insurance 
status, and education level. Sexual and reproductive history variables included age at 
menarche and whether participants had ever been sexually active, pregnant, used hormonal 
birth control, had a gynecologic exam, or were currently using birth control. As part of the 
medical history, participants completed the 4-item Patient Health Questionnaire-4 (PHQ-4), 
which consists of a 2-item depression scale and a 2-item anxiety scale. Scores > 3 suggest 
clinical depression or anxiety, respectively.19 The single-item provider-rated anxiety variable 
was dichotomous (yes or no). Pain at IUD insertion was recorded using a 100 mm visual 
analog scale (VAS). Participants touched a line anchored from “no pain” (0 mm) to “worst 
pain in my life” (100 mm) using an iPad at seven time points: baseline (prior to placement in 
lithotomy), immediately after speculum placement, tenaculum placement, block 
administration, uterine sounding, IUD insertion, and 5-minutes after speculum removal. The 
pain score reported immediately after IUD insertion, which was the primary outcome for the 
Akers et al. Page 4
Obstet Gynecol. Author manuscript; available in PMC 2018 August 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
parent study, was included in the models. Treatment group assignment (paracervical block 
versus sham block group) was also included.
Analysis
Between-group differences in the baseline characteristics for the treatment groups were 
compared using chi-square test for proportions, Fisher’s exact test for small numbers, and 
Wilcoxon rank-sum tests for continuous data that were not normally distributed.
Each of the three outcome variables were ordinal and highly skewed, with more than two-
thirds of participants selecting the highest response category reflecting high overall 
satisfaction with the procedure, high likelihood of recommending an IUD to a friend, and a 
strong belief that the IUD was worth the discomfort. All three outcomes were therefore 
dichotomized to compare the highest response category to all the other response categories 
combined. Separate logistic regression models were run for each of the 3 dependent 
variables.
Predictor variables with small sample sizes (< 10% of respondents per cell) were excluded 
from analysis (i.e., Hispanic ethnicity, marital status, ever sexually active, prior pregnancy, 
self-reported depression and anxiety, and provider rating of participant’s anxiety). The 
variable assessing whether participants had ‘ever used birth control’ was excluded as it was 
highly correlated with the variable assessing ‘current birth control use’, which was included. 
Age was dichotomized to assess whether younger age (14 to 17 years) or older age (18 to 22 
years) was a significant predictor of each outcome. Race was dichotomized as White vs non-
White. Education level was continuous with higher levels reflecting more education. 
Number of prior gynecologic exams and pain scores following IUD insertion were used as 
predictors of each outcome as well. ORs and 95% CIs estimates in the multivariable models 
were robust to the number of predictors selected.
Two-tailed p-values less than .05 were considered significant. Analyses were completed with 
SAS software, version 9.3 (SAS Institute).
RESULTS
Of the 95 participants who enrolled in the trial, 93 were included in the outcome analysis. 
One was dropped due to missing insurance data and the other due to missing pain score at 
IUD insertion. Participant characteristics are shown in Table 1. The mean age of the sample 
was 19.4 ± 2.1. Almost half were white (47.4%) and a third were black (36.0%). Most were 
ages 18 to 22 years (80.0%), never married (95.8%), had at least some college education 
(67.4%), and were privately insured (66.0%). Most also reported having had sex at least 
once (91.6%) and prior contraceptive use (79.0%); few reported current contraceptive use 
(43.2%) or a prior pregnancy (4.2%). Two-thirds (69.5%) reported having a prior 
gynecologic exam; the types of gynecologic exams varied, with 59.0% reporting a prior 
visual inspection of the vulva, 51.6% reported a prior bimanual exam, 44.2% reported a 
prior speculum exam, and 30.5% reported a prior pap smear.
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Participants were equally distributed among the treatment groups with 47 randomized to the 
paracervical block group and 48 to the sham group (Figure 1). The baseline characteristics 
were similar in both groups, except those in the paracervical block group were less likely to 
be current contraceptive users compared to those in the sham group (31.9% versus 54.2%, 
p=0.03). The median pain score (± interquartile range [IQR]) reported immediately 
following IUD insertion for the sample was 63.5±53, with lower scores in the lidocaine 
paracervical block group compared to the sham block group (30.0±52, versus 71.5±23.5, 
p<0.0001)
Overall Satisfaction with IUD insertion
Most participants reported being “very satisfied” with their IUS insertion procedure (n=73, 
76.8%), with 14 (14.7%) being “somewhat satisfied”, 6 (6.3%) were “neutral”, 1 (1.1%) 
were “somewhat dissatisfied”, and 1 (1.1%) were very dissatisfied. There were no 
differences in satisfaction between the lidocaine block group compared to the sham group 
(91.5% versus 91.7%, p=0.30).
As shown in Table 2, the odds of reporting higher overall satisfaction were lower among 
younger adolescents compared to older adolescents (OR 0.07; 95% Confidence Interval 
(CI): 0.008, 0.68); among those who had never had a gynecologic exam compared to those 
who had (OR 0.26; 95% CI: 0.069, 0.99); and decreased as the pain score following IUD 
insertion increased (OR 0.96; 95% CI: 0.94, 0.99).
Would Recommend an IUD to a Friend
When asked if they would recommend an IUD to a friend, 64 (67.4%) said “definitely yes”, 
20 (21.1%) “probably yes”, 6 (6.3%) were neutral, 3 (3.2%) “probably low”, and 2 (2.1%) 
“definitely no”. There were no differences in recommending an IUD insertion to a friend 
among the lidocaine block group compared to the sham group, (91.5% versus 85.4%, 
p=0.45). As shown in Table 2, the odds of recommending an IUD to a friend decreased as 
the pain score following IUD insertion increased (OR 0.96, 95% CI: 0.941–0.986). Odds of 
recommending an IUD to a friend were lower among those who had never had a 
gynecologic exam compared to those who had, but this did not reach statistical significance 
(OR 0.32; 95% CI: 0.10, 1.01).
IUD was Worth the Discomfort
Most participants endorsed that getting the IUD was “worth the level of discomfort” (n=79, 
83.2%), none reported that it was “not worth the level of discomfort” and 16 (16.8%) were 
“unsure at this time”. There were no differences between the lidocaine block group 
compared to the sham group (44.2% versus 39.0%, p=0.11). As shown in Table 2, the odds 
of reporting that getting the IUD was worth the discomfort decreased as the pain score 
following IUD insertion increased (OR 0.96, 95% CI: 0.93–0.99).
DISCUSSION
Utilization of IUDs is low among adolescents and young adult women, in part due to fears 
regarding discomfort during the insertion process.7,8,12 In this secondary data analysis study, 
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we examined three dimensions of satisfaction with the IUD insertion procedure among 
adolescent and young adult women. We found that the majority of young women reported 
high satisfaction with the IUD insertion procedure. Eight of ten women reported high overall 
satisfaction with the procedure and believed the procedure was worth the discomfort they 
experienced. Seven of 10 would recommend an IUD to a friend. Higher pain during IUD 
insertion was the only variable associated with lower odds of satisfaction with the procedure 
on all 3 satisfaction measures.
Patient satisfaction is an important aspect of evaluating the quality of healthcare services,
20,21
 with pain management increasingly recognized as being highly correlated with 
satisfaction.20 Few studies have examined associations between pain management and 
patient satisfaction with procedures performed in outpatient clinic settings. This study 
therefore fills an important gap.
Our finding that higher pain during the IUD insertion procedure was the only variable 
consistently associated with reduced odds of satisfaction with the IUD insertion procedure 
suggests that pain-reduction interventions may be important for young women. Moreover, 
the finding that younger adolescents and those with no prior gynecologic exam were less 
likely to be satisfied with the IUD insertion procedure suggests that patients with these 
characteristics, in particular, may derive benefit from routine use of a paracervical block, 
other interventions designed to enhance procedure tolerance, or the opportunity to undergo 
IUD placement under sedation. In the current study, a 10 mL paracervical block with 1% 
lidocaine was used. Future studies should consider examining the effectiveness of other pain 
control interventions that are currently understudied in this population, including the 4-site 
paracervical block, lidocaine spray or gel applied to the cervix prior to placing a paracervical 
block, or using a higher dose of a lidocaine paracervical block.
We found no differences in patient satisfaction in the sham block group and paracervical 
block group despite the sham group reporting significantly more pain with the procedure. 
Similar to our study, prior randomized controlled trials assessing the effectiveness of various 
pain medications in reducing pain during IUD insertion have consistently noted high rates of 
satisfaction with the IUD insertion procedure, regardless of the pain control regimen used.
22–24
 None of these studies, including our current study, assessed how motivated women 
were to have an IUD placed. Patients who are highly motivated to get an IUD may report 
high satisfaction due to receiving the contraceptive method of their choice, despite 
experiencing pain during the insertion procedure. Assessing young women’s motivations for 
using an IUD is an under-explored area that may be important for better understanding the 
relationship between patient satisfaction and reported pain.
There are a number of limitations in the current study. Although there are 4 hormonal IUDs 
on the market, we examined satisfaction with insertion of only the 13.5 mg levonorgestrel 
13.5 mg IUD; these findings may not extend to other types of IUDs. We only examined 
satisfaction immediately following the IUD insertion, but patient satisfaction might change 
over time. In particular, participants’ perception that going through the IUD insertion 
process was worth the discomfort and their willingness to recommend an IUD to a friend 
might change depending on their experience with the method over time. Another key 
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limitation was that our study was powered to assess pain control, not patient satisfaction. It 
is possible that had we powered the study to assess patient satisfaction, we may have seen 
different results. Young age (age 14 – 17 years) was noted to be associated with decreased 
overall satisfaction, but the small size of this group (less than a quarter of analyzed 
participants) likely limited subgroup analyses by age. Finally, there are some predictors that 
may influence patient satisfaction that we could not analyze due to too few of our subjects 
reporting those predictors. If we had a larger sample size, predictors such as anxiety or 
depression may have influenced patient satisfaction.
CONCLUSION
Adolescents and young women report high overall satisfaction with the IUD insertion 
procedure, whether or not they receive a paracervical block. Although younger age, lack of 
experience with a gynecologic exam, and higher pain were inversely associated with 
satisfaction, most young women consider receiving an IUD to be worth the discomfort. 
Future research should evaluate satisfaction with the IUD over a longer time period, as well 
as other interventions to improve the IUD insertion experience for younger adolescents.
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Table 1
Characteristics of Participants, by treatment group (N=95)
Covariates Total Sample (N=95)
n (%)
Block Group (N= 47)
n (%)
Sham Group (N= 48)
n (%)
Mean age in years ± SD1 19.4±2.1 19.3±2.1 19.5±2.1
Age group
 Ages 14 – 17 years 19 (20.0) 10 (18.8) 9 (18.8)
 Ages 18 – 22 years 76 (80.0) 37 (78.7) 39 (81.3)
Primary Race
 White 45 (47.4) 15 (31.9) 19 (39.6)
 Black 34 (36.0) 23 (48.9) 22 (45.8)
 Other 16 (16.8) 9 (19.2) 7 (14.6)
% Non-Hispanic 86 (90.5) 42 (89.4) 44 (91.7)
Marital Status
 Never married, not living with partner 91 (95.8) 46 (97.9) 45 (93.8)
 Never married, living with partner 3 (3.2) 1 (2.1) 2 (4.2)
 Married, living with partner 1 (1.1) 0 (0.0) 1 (2.1)
Education
 Less than high school degree 22 (23.2) 11 (23.4) 11 (22.9)
 High school degree or equivalent 9 (9.5) 5 (10.6) 4 (8.3)
 Some college or higher 64 (67.4) 31 (66.0) 33 (68.8)
Insurance
 None 1 (1.1) 0 1 (2.1)
 Public insurance 29 (30.9) 15 (32.6) 14 (29.2)
 Private insurance 62 (66.0) 30 (65.2) 32 (66.7)
 None or other 2 (2.1) 1 (2.2) 1 (2.1)
Age at menarche in years ±SD 11.9±1.6 11.7±1.7 12.1±1.5
Ever sexually active 87 (91.6) 44 (93.6) 43 (89.6)
Prior pregnancy 4 (4.2) 2 (4.3) 2 (4.2)
Ever used hormonal birth control 75 (79.0) 37 (78.7) 38 (79.2)
Currently using hormonal birth control 41 (43.2) 15 (31.9) 26 (54.2)
Prior gynecologic exam 66 (69.5) 34 (72.3) 32 (66.7)
Median number of prior gynecologic exams ±IQR2 2.0±3.0 2.0±3.0 2.0±3.0
% Clinically anxiety 2 (2.1) 1 (2.1) 1 (2.1)
% Clinically depressed 2 (2.1) 2 (4.26) 0 (0.0)
% Provider-rated participant anxiety 9 (9.5) 5 (10.6) 4 (8.3)
1SD=standard deviation
2
Interquartile range (IQR)
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